Press Releases

Bioengineered Head Device Stops Alzheimer’s Memory Loss for 2 1⁄2 Years

Groundbreaking Alzheimer’s Treatment Study

NeuroEM Therapeutics Awarded $2.2M Grant from National Institute on Aging for Promising Device Against Alzheimer’s Disease

First-Ever Treatment Shown to Reverse Alzheimer’s Earns NeuroEM Therapeutics FDA Breakthrough Device Status

Alzheimer’s Memory Loss Reversed by New Head Device Using Electromagnetic Waves

NeuroEM Therapeutics Announces Completion of Clinical Trial Testing Its Novel Head Device Against Alzheimer’s Disease

Alzheimer’s Clinical Trial Begins with Pioneering Medical Device

National Institutes of Health Bestows Grant to NeuroEM Therapeutics and Arizona State University for Collaborative Research in Alzheimer’s Disease

NeuroEM Therapeutic’s CEO provides keynote address at Australian conference on biologic effects of electromagnetic exposure

Angel Investment Forum Provides “Series Seed” Funding to NeuroEM Therapeutics to Support Development of Medical Device against Alzheimer’s Disease